Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 15;71(19):e127-e248.
doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13.

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Paul K Whelton, Robert M Carey, Wilbert S Aronow, Donald E Casey Jr, Karen J Collins, Cheryl Dennison Himmelfarb, Sondra M DePalma, Samuel Gidding, Kenneth A Jamerson, Daniel W Jones, Eric J MacLaughlin, Paul Muntner, Bruce Ovbiagele, Sidney C Smith Jr, Crystal C Spencer, Randall S Stafford, Sandra J Taler, Randal J Thomas, Kim A Williams Sr, Jeff D Williamson, Jackson T Wright Jr
Free article
Review

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Paul K Whelton et al. J Am Coll Cardiol. .
Free article

Erratum in

  • Correction.
    [No authors listed] [No authors listed] J Am Coll Cardiol. 2018 May 15;71(19):2275-2279. doi: 10.1016/j.jacc.2018.03.016. J Am Coll Cardiol. 2018. PMID: 29747841 No abstract available.
No abstract available

Keywords: ACC/AHA Clinical Practice Guidelines; ambulatory care; antihypertensive agents; behavior modification; blood pressure; chronic kidney disease; diabetes; hypertension; hypertension emergency; lifestyle measures; measurement; nonpharmacologic treatment; resistant hypertension; risk reduction; secondary hypertension; systems of care; treatment adherence; treatment outcomes.

PubMed Disclaimer

Comment in